The original site for employees in pharma, medical, and diagnostic sales and related industries. Join us and stay informed.

18267 followers  •  300 follow  •    •

CSL takes the wraps off a big new R&D center as it eyes vaccines, cell and gene therapies

AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved

AstraZeneca wins federal class-action suit, judge dismisses shareholders' misleading claims

Bayer's hunt for a new CEO is on, suggesting Werner Baumann could be headed for an early exit: report

Novome gets $43.5M boost for its engineered microbiome therapies

Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.


ESC: Amarin's Vascepa reduces patients' arterial plaque after 18 months of treatment

One of biotech’s biggest conferences grapples with how to talk about race and identity

Johnson & Johnson’s Covid-19 vaccine receives interim order authorization in Canada

GV, Sanofi drive British biotech OMass to $100M series B, fueling work on undruggable targets

5 trends that will shape healthcare in 2021

FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio

Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

FDA’s Hahn Apologizes for Overstating Benefit of COVID-19 Plasma Treatment

Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets